How Long After Injecting Wegovy Does It Work?

The first 24 hours: what the injection is doing while you wait

You've injected, and nothing dramatic happens. That's expected. Semaglutide is a GLP-1 receptor agonist, meaning it mimics a gut hormone that your body releases naturally after eating, signalling fullness to the brain, slowing the rate at which food leaves the stomach, and nudging the pancreas to work more efficiently with insulin. After a subcutaneous injection, the medicine is absorbed slowly from the tissue beneath the skin rather than entering the bloodstream in one rush. Blood concentration rises gradually and reaches its peak somewhere between 24 and 72 hours after the dose, according to the NHS semaglutide medicines page. At the starting dose of 0.25mg (which exists purely to help your system adjust rather than to produce weight loss) that peak concentration is low. Most people feel nothing the first week, and if you're curious about how long a semaglutide injection takes to work, the honest answer is that meaningful effects build over several weeks rather than days. A mild wave of nausea is the most common early signal that the medicine has arrived; if it comes, it usually settles within a few days. The injection technique matters here too: rotating sites between your abdomen, thigh or upper arm, and letting the skin settle before injecting, can make that adjustment easier. Our injection tutorial page walks through the correct steps.

Weeks one to eight: when appetite starts to shift

The titration schedule (0.25mg, then 0.5mg, then 1.0mg, stepping up roughly every four weeks) is designed to reduce side effects while the body acclimates. Appetite suppression tends to arrive in stages that mirror those dose increases. Some people notice it early: food stops feeling urgent, a meal that would normally have been finished is left half-eaten. Others notice nothing until the 1.0mg or 1.7mg mark. Both patterns are clinically normal. If you want a clearer picture of how long after injection Wegovy starts to work, most people find that noticeable appetite changes emerge gradually across the first few dose increases rather than after any single jab. Gastrointestinal effects (nausea, looser stools, constipation, reflux) are most common in the early weeks and around each dose step. They are generally mild and settle, but if they are severe or persistent, your prescriber needs to know. You can explore how Wegovy works in more detail including what to expect at each stage of the titration.

Months two to eighteen: where the clinical evidence sits

The STEP 1 trial (68 weeks, semaglutide 2.4mg against placebo, published in the New England Journal of Medicine) found an average weight reduction of around 15% of body weight. That figure represents sustained weekly treatment reaching a maintenance dose of 2.4mg, with lifestyle changes alongside. No single injection produces it; no specific week does either. The weight loss curve in the trial data tends to steepen between weeks eight and thirty-two, then plateaus, which is worth bearing in mind when you read about how long after a Wegovy injection it starts working, since the full effect unfolds over many months rather than a single dose cycle. One practical note: if you're considering the cost of Wegovy across UK providers, keep in mind that the treatment is designed to run for many months, the price-per-month calculation matters more than the price of the first pen. If less than 5% weight loss has occurred after six months at the highest tolerated dose, your prescriber will review whether continuing is the right course; NICE guidance for semaglutide makes this part of the clinical framework. That review is a standard checkpoint, not a failure. Stop-start use does not replicate the sustained GLP-1 signal the trial data is based on; missing doses should always be discussed with your prescriber rather than managed alone.

When to contact a clinician, and what can't wait

Most of the early weeks are uneventful. A few signals warrant prompt attention. Severe stomach pain that radiates to the back (with or without vomiting) should be treated as urgent; the MHRA highlighted acute pancreatitis as a known, infrequent but serious risk across GLP-1 medicines in a January 2026 Drug Safety Update, and rapid assessment matters. Suspected allergic reactions, significant dehydration from prolonged vomiting or diarrhoea, and any sudden changes in mood or mental state also warrant same-day contact with a clinician. Side effects or concerns about your treatment can be reported directly to the MHRA via the Yellow Card scheme. At nume, aftercare support runs seven days a week, our contact page has the details. If you have questions about semaglutide more broadly, our FAQs cover many of the practical points. When treatment is going well, the work between injections (consistent meals, adequate protein, staying hydrated) is what the clinical evidence suggests helps people get the most from each week's dose. If you haven't yet started and want to understand your options, start a free consultation with our GPhC-registered prescribers.